Clinical Trial Update: Everolimus in Combination With Cyclosporine A and Prednisolone for the Treatment of Graft Versus Host Disease [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating everolimus combined with cyclosporine A and prednisolone for graft-versus-host disease; the study status is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Cyclosporine A (cyclosporine)
• Everolimus (everolimus)
• Prednisolone (Prednisolone)

Snippet

Sponsor: University Hospital Tuebingen | Conditions: Graft Versus Host Disease | Phase 1 | Status: TERMINATED